Probiotics: Should We Use Them Proactively in Critical Illness?

Area of Science:

• Critical care medicine
• Microbiology
• Gastroenterology

Background:

• The role of probiotics in critical illness is debated.
• Evidence regarding their efficacy and safety in intensive care units (ICUs) is inconsistent.

Discussion:

• Probiotics are live microorganisms intended to confer a health benefit.
• Their use in critical illness could potentially alter gut microbiota, but clinical outcomes are uncertain.
• Potential risks include translocation and sepsis in vulnerable patients.

Key Insights:

• Current research does not strongly support the routine proactive administration of probiotics in critical care.
• The potential benefits do not clearly outweigh the risks or costs in most ICU populations.
• More high-quality research is needed to define specific patient subgroups who might benefit.

Outlook:

• Future studies should focus on personalized approaches and specific probiotic strains.
• Investigating the impact on gut microbiome modulation and clinical endpoints is crucial.
• A cautious approach to probiotic use in critical illness is warranted pending further evidence.